Director, V&A Marketing and Strategy, Oncology
Ipsen
Summary
The Director, Value and Access, Marketing & Strategy will be aligned to the Oncology business Unit and has accountability for developing, refining and executing innovative, integrated programs across various channels at the time of launches and beyond to drive sustained brand growth. Key components of this role will include value proposition development, creation of Value & Access (V&A) marketing materials, agency management, budget management, competitive strategy, annual business and strategic plans, quarterly business reviews with executive leadership, message development and execution. It will require collaboration with V&A partners, vendors and agencies to ensure strategies and tactics are well integrated across brand campaigns and meet brand priorities. The role will also lead V&A Enterprise Marketing, driving consistency with both internal and external stakeholders. The Director, V&A Marketing & Strategy reports to the Head of V&A Strategy & Operations. In partnership with the V&A Leadership Team, this person helps to define objectives for the V&A organization, shape the culture, and drive effective alignment within the V&A Business Unit. This role requires active engagement with senior leaders, cross-functional partners and the entire V&A team to communicate opportunities for increased efficiency and effectiveness and to establish and administer key business processes.
Job description
Main Responsibilities
- Determine marketing resource needs for all V&A verticals (Corporate Accounts, National and Regional Accounts, Trade, Field Reimbursement, Pricing & Contracting and Patient Services) within the Oncology Business Unit
- Develop value propositions for formulary decision makers (Payers, PBMs, GPOs, Institutions) with a focus on the Oncology Business Unit
- Serve as one of 3M (Marketing, Medical, Market Access) leaders of US Brand Team(s) for each brand within the Oncology Business Unit, representing Value & Access
- Serve as member of the Oncology Business Unit Leadership Team (OBULT), representing Value & Access and demonstrating subject matter expertise across all V&A verticals
- Lead Value & Access launch planning for any current/future launches within the Business Unit
- Collaborate with Marketing/Brand teams to determine access marketing resources needs for Business Unit
- Co-Design, with V&A Groups and considering brand priorities, the strategic priorities for V&A resources for each brand with the Business Unit
- Represent the V&A team in key brand activities including annual planning, pull-through, product launch, training, forecasting, etc.
- Work with brand team and vendors to review and create pieces aligned with the strategy, prioritizing strategic brands, and to streamline currently used V&A tools
- Shepperd resources through the Promotional Review Committee (PRC) process
- Manage critical business planning frameworks and activities, such as budget management, business reviews, business unit executive meeting content, senior leadership briefings and presentations, etc.
Knowledge & Experience
- At least 8 - 10 years of experience with a focus on payer marketing & reimbursement tools within biopharma
- Experience working within a competitive space
- Previous experience working with agencies on creation of materials
- Previous experience working with promotional material review committees (legal, regulatory, medical) and managing new product launch or label expansion
- Strong project management skills, setting and executing against deadlines and delivering on commitments
- Experience with both Pharmacy and Medical benefit products, with knowledge of Rare Disease, Oncology and Neurology preferred
- Thorough understanding of the commercialization of biopharmaceuticals, including brand management, sales planning and execution, market access, and regulatory environments
- Proven track record for consistently meeting or exceeding quantitative and qualitative targets
- Demonstrated ability to interact with internal stakeholders, including senior leaders across commercial and internal functions
- Excellent communication and collaboration skills
- Ability to work in a hybrid work arrangement including in-office and remote based working from our Cambridge, MA office 3 days per week on average
Education / Certifications
- BA/BS is required
- MBA or advanced degree in a quantitative field is strongly preferred
Language(s)
English
Requirements
- At least 8 - 10 years of experience with a focus on payer marketing & reimbursement tools within biopharma
- Experience working within a competitive space
- Previous experience working with agencies on creation of materials
- Previous experience working with promotional material review committees (legal, regulatory, medical) and managing new product launch or label expansion
- Strong project management skills, setting and executing against deadlines and delivering on commitments
- Experience with both Pharmacy and Medical benefit products, with knowledge of Rare Disease, Oncology and Neurology preferred
- Thorough understanding of the commercialization of biopharmaceuticals, including brand management, sales planning and execution, market access, and regulatory environments
- Proven track record for consistently meeting or exceeding quantitative and qualitative targets
- Demonstrated ability to interact with internal stakeholders, including senior leaders across commercial and internal functions
- Excellent communication and collaboration skills
- Ability to work in a hybrid work arrangement including in-office and remote based working from our Cambridge, MA office 3 days per week on average
- BA/BS is required
- MBA or advanced degree in a quantitative field is strongly preferred
- English
Benefits
- 401(k) Matching
- Medical, Dental & Vision
- Life Insurance
- Disability Insurance
- Flexible Spending Accounts
- Parental Leave
- Paid Time Off
- Winter Shutdown
- Well-Being Allowance
- Commuter Benefits
- Incentive Compensation
- Long-Term Incentives
Company overview
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a global presence in over 40 countries. Founded in 1929 by Henri Beaufour, the company has evolved into a leading mid-size pharmaceutical firm specializing in three key therapeutic areas: oncology, rare diseases, and neuroscience. With approximately 5,300 employees worldwide, Ipsen operates as a publicly traded company on Euronext Paris while maintaining significant family ownership through the Beaufour family. The company's portfolio includes innovative treatments such as Cabometyx for advanced cancers, Dysport for neurological conditions, and Bylvay for rare liver diseases. Ipsen has established itself as one of the world's top 15 biopharmaceutical companies in oncology sales, with medicines registered in 88 countries and direct commercial operations in over 30 nations. The company maintains four global R&D hubs and three pharmaceutical development centers, investing significantly in research and development to advance transformative medicines for patients with limited treatment options.